Radiopharm Theranostics Management
Management criteria checks 2/4
Radiopharm Theranostics' CEO is Riccardo Canevari, appointed in Sep 2021, has a tenure of 3.17 years. total yearly compensation is A$2.65M, comprised of 31.8% salary and 68.2% bonuses, including company stock and options. directly owns 0.62% of the company’s shares, worth A$348.50K. The average tenure of the management team and the board of directors is 3.1 years and 2.6 years respectively.
Key information
Riccardo Canevari
Chief executive officer
AU$2.7m
Total compensation
| CEO salary percentage | 31.8% |
| CEO tenure | 3.2yrs |
| CEO ownership | 0.6% |
| Management average tenure | 3.1yrs |
| Board average tenure | 2.6yrs |
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | AU$3m | AU$844k | -AU$48m |
| Mar 31 2024 | n/a | n/a | -AU$47m |
| Dec 31 2023 | n/a | n/a | -AU$47m |
| Sep 30 2023 | n/a | n/a | -AU$41m |
| Jun 30 2023 | AU$3m | AU$825k | -AU$35m |
| Mar 31 2023 | n/a | n/a | -AU$30m |
| Dec 31 2022 | n/a | n/a | -AU$26m |
| Sep 30 2022 | n/a | n/a | -AU$28m |
| Jun 30 2022 | AU$3m | AU$631k | -AU$30m |
Compensation vs Market: Riccardo's total compensation ($USD1.71M) is above average for companies of similar size in the Australian market ($USD295.69K).
Compensation vs Earnings: Riccardo's compensation has been consistent with company performance over the past year.
CEO
Riccardo Canevari
3.2yrs
Tenure
AU$2,652,983
Compensation
Mr. Riccardo Canevari is Managing Director & Chief Executive Officer since September 13, 2021 and Director at Radiopharm Theranostics Limited. He was Chief Commercial Officer of Advanced Accelerator Applic...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder & Executive Chairman | 3.8yrs | AU$478.85k | 6.87% A$ 3.9m | |
| MD, CEO & Director | 3.2yrs | AU$2.65m | 0.62% A$ 348.5k | |
| CFO, Joint Company Secretary & Director | no data | AU$27.71k | 0.73% A$ 414.9k | |
| Chief Business Officer | no data | AU$579.19k | 0.046% A$ 26.0k | |
| Chief Medical Officer | less than a year | no data | no data | |
| Joint Company Secretary | 3.1yrs | no data | no data |
3.1yrs
Average Tenure
68yo
Average Age
Experienced Management: RAD's management team is considered experienced (3.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder & Executive Chairman | 3.8yrs | AU$478.85k | 6.87% A$ 3.9m | |
| MD, CEO & Director | no data | AU$2.65m | 0.62% A$ 348.5k | |
| CFO, Joint Company Secretary & Director | less than a year | AU$27.71k | 0.73% A$ 414.9k | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Non-Executive Director | 3.6yrs | AU$476.52k | 0.23% A$ 128.8k | |
| Non-Executive Director | 2.4yrs | AU$165.41k | 0.049% A$ 27.9k | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Non-Executive Director | 2.8yrs | AU$94.32k | 0.030% A$ 16.8k | |
| Member of Scientific Advisory Board | 2.4yrs | no data | no data |
2.6yrs
Average Tenure
Experienced Board: RAD's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.